Satsuma Pharma: STS101 Fails To Meet Statistical Significance On Co-primary Endpoints

Satsuma Pharmaceuticals, Inc. (STSA) announced topline results from its phase 3 EMERGE efficacy trial of STS101 powder as an acute treatment for migraine. The company said topline data from the study did not show statistically significant differences between either dosage strength of STS101 and placebo on co-primary endpoints of freedom from pain and most bothersome symptom at two hours post-administration. STS101 was well-tolerated in the trial.

The company said analysis of EMERGE trial data is ongoing, and it expects to provide a detailed update on its business plans after these analyses are completed.

Headquartered in South San Francisco, California, Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing STS101. Shares of Satsuma Pharma were down 83% in pre-market trade on Thursday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Oilfield services company Schlumberger Ltd. reported Friday a profit for the fourth quarter that surged 61 percent from last year, reflecting 13 percent higher revenues amid growth across all segments and regions. Both adjusted earnings per share and quarterly revenues topped analysts' estimates. Twitter Inc. has launched a new feature to allow some users of its Blue subscriber service to keep non-fungible tokens or NFTs as their profile pictures. Twitter Blue is now available in the US, Canada, Australia, and New Zealand. NFT is a crypto token, which is non-fungible, meaning that it can neither be transferred like money nor replaced with something else. Frozen Food Development is recalling specific lots of Lidl branded 12-ounce packages of Frozen Chopped Spinach citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The product comes in 12-ounce poly bags, and items included in the recall are marked with lot # R17742 or R17963 on the back of the poly bag with a best by date of 09/10/23.
Follow RTT